当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第1期
编号:13329661
代谢组学在衰老研究中的进展(4)
http://www.100md.com 2019年1月5日 《中国医药导报》 2019年第1期
     [20] Darshi M,Van EB,Sharma K. Metabolomics in diabetic kidney disease: unraveling the biochemistry of a silent killer [J]. American Journal of Nephrology,2016,44(2):92-103.

    [21] Batova A,Altomare D,Creek KE,et al. Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma [J]. Plos One,2017,12(3):e0172632.

    [22] 赵欢,周斌.细胞衰老研究现状[J].中国细胞生物学学报,2017,39(6):687-694.

    [23] Park J Y,Lee SH,Shin MJ,et al. Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction [J]. PLoS One,2015, 10(8):e0135228.

    [24] Fernandez C,Sandin M,Sampaio JL,et al. Plasma lipid composition and risk of developing cardiovascular disease [J]. PLoS One,2013,8(8):e71846.

    [25] Anstey KJ,Ashby-Mitchell K,Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia:review and meta-analysis [J]. J Alzheimers Dis,2017,56(1):215.

    [26] Leoni V,Caecia C. 24s-hydroxycholesterol in plasma:a marker of cholesterol turnover in neurodegenerative diseases [J]. Biochimie,2013,95(3):595-612.

    (收稿日期:2018-05-16 本文编辑:苏 暢), 百拇医药(刘传铃 王佳贺)
上一页1 2 3 4